High Tacrolimus Intra‐Patient Variability and Adverse Outcomes in Cardiac Transplant Recipients: A Single‐Center Study in China
Cardiac transplant recipients with high tacrolimus IPV may be at increased risk of adverse events such as infections. Tacrolimus IPV, which is simple to calculate, can serve as a useful follow-up tool for predicting postoperative adverse outcomes.
Authors
- Lin Guo (ORCID: https://orcid.org/0000-0002-5910-3464)
- Hua Zheng (ORCID: https://orcid.org/0000-0002-8631-6748)
- Hongxiang Zheng
- Yunfei Liu
- Mian Zhang
- Yibo Wang
- Zhenzhen Wang
- Bin Yang
- Dong Zeng
Institutions
- Zhengzhou People's Hospital (CN)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1111/ctr.70427
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00